Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Select Medical Holdings Corporation Q1 2026 Earnings Call - Take-Private Deal Nears Close Amid Mixed Earnings and Regulatory Headwinds
Select Medical Holdings delivered a mixed first quarter, with revenue up 5% but adjusted EBITDA falling 6.5% as the Critical Illness Recovery Hospital division struggled with a 15% margin compression....
- Take-Private Deal Nears Closure: The consortium led by Executive Chairman Robert Ortenzio and Welsh, Carson, Anderson & Stowe received unanimous board approval to acquire Select Medical for $16.50 per share. The Hart-Scott-Rodino waiting period expired on April 27, and the transaction is expected to close in mid-2026, subject to remaining regulatory and shareholder approvals.
- Debt Load Increases with Transaction: Contingent on the take-private deal, the company will secure an additional $1 billion in term loan borrowings at SOFR plus 3%. Total debt currently stands at $1.9 billion, with a leverage ratio of 3.75x under senior secured credit agreements.
- Revenue Growth Driven by Inpatient Rehab: Consolidated revenue rose 5% year-over-year, with the Inpatient Rehabilitation Hospital division leading the charge with a 14% revenue increase to $351.9 million. Average daily census grew 12%, and same-store occupancy reached 87%.
- +7 more takeaways
Aon PLC Q1 2026 Earnings Call - Broad-Based Growth Driven by AI and Data Center Demand
Aon delivered a disciplined first quarter, posting 5% organic revenue growth and a 70-basis-point expansion in adjusted operating margins to 39.1%. The results underscore the 3x3 Plan’s core thesis: A...
- Organic revenue grew 5% in Q1 2026, with total revenue reaching $5 billion, in line with mid-single-digit guidance.
- Commercial Risk delivered 7% organic growth for the fourth consecutive quarter, driven by double-digit construction growth and strong M&A activity.
- Data center demand is a structural tailwind, with the construction pipeline running three times higher than the prior year, though it is one component of broad-based growth.
- +7 more takeaways
Materion Corporation Q1 2026 Earnings Call - Record Backlog and AI-Driven Margin Expansion Signal Accelerating Growth
Materion Corporation delivered a record-breaking first quarter of 2026, driven by surging AI demand across its semiconductor, aerospace, and defense end markets. Electronic Materials sales jumped 18% ...
- Materion reported record first-quarter adjusted EBITDA margins of 20.2%, driven by volume growth, favorable price mix, and operational improvements, particularly in Electronic Materials.
- Electronic Materials sales surged 18% year-over-year, fueled by AI-led demand for high-performance memory, data storage, and power applications.
- Precision Optics delivered a 43% year-over-year sales increase, marking its strongest quarter since 2021 and fifth consecutive quarter of profitability improvement.
- +9 more takeaways
Fulgent Genetics 1st Quarter 2026 Earnings Call - Revenue Guidance Reiterated Despite Customer Loss, Margin Pressure, and Aggressive Buybacks
Fulgent Genetics reported a disappointing Q1 2026, with revenue falling to $71.1 million as its largest customer shifted testing in-house and claims processing backlogs lingered. Gross margins compres...
- Revenue fell 14.6% sequentially to $71.1 million, driven by volume decline from the largest customer transitioning testing in-house and timing delays in claims processing.
- Non-GAAP gross margin compressed to 32.3% as fixed costs were spread over a lower revenue base, with management expecting normalization as volumes recover.
- Management reiterated full-year 2026 revenue guidance of $350 million, anticipating that Bako Diagnostics and StrataDX contributions (~$53 million) will offset the largest customer loss in H2.
- +12 more takeaways
Magna International Q1 2026 Earnings Call - Margin Expansion and Cash Flow Surge
Magna International delivered a robust Q1 2026, with sales up 3% year-over-year and adjusted EBIT margin expanding 190 basis points to 5.4%. Adjusted EPS surged 77% to $1.38, driven by strong operatio...
- Q1 2026 sales reached $10.4 billion, up 3% year-over-year, with weighted growth exceeding market by 3%. Excluding foreign currency, sales were down 2%, reflecting a 7% decline in global light vehicle production.
- Adjusted EBIT margin expanded 190 basis points to 5.4%, with adjusted EBIT up 58% to $558 million. Adjusted EPS rose 77% to $1.38, surpassing expectations.
- Free cash flow surged to $372 million, up $685 million from the prior year, driven by $677 million in operating cash flow and improved working capital management.
- +7 more takeaways
Lazard Q1 2026 Earnings Call - Campbell Lutyens Acquisition and Private Capital Advisory Expansion
Lazard delivered a solid first quarter of 2026, with firm-wide adjusted net revenue rising 5% to $673 million. The quarter was defined by the strategic acquisition of Campbell Lutyens, which establish...
- Lazard announced the acquisition of Campbell Lutyens, creating Lazard CL, a new global private capital advisory unit. The deal is expected to close before the end of 2026 and will make Lazard the leading primary and secondary fundraising advisor globally with approximately $500 million in anticipated combined 2027 revenue.
- Firm-wide adjusted net revenue for Q1 2026 was $673 million, up 5% year-over-year, driven by strong performance in asset management and restructuring, which offset a 4% decline in financial advisory revenue.
- Asset management reported $9 billion in net inflows, the highest quarterly net flows in nearly 20 years. Average AUM was $266 billion, up 15% year-over-year, with management fees rising 25% to $296 million.
- +7 more takeaways
Moderna Q1 2026 Earnings Call - EU mCOMBRIAX Approval and UK Partnership Drive Revenue Growth
Moderna delivered a strong first quarter in 2026, with revenue jumping to $400 million, driven by a strategic partnership with the U.K. government and the continued rollout of its COVID vaccines. The ...
- Q1 2026 revenue reached $400 million, exceeding guidance and marking a $300 million year-over-year increase, primarily fueled by deliveries under a long-term strategic partnership with the U.K. government.
- Moderna reiterated its full-year 2026 revenue growth target of up to 10%, with an expected geographic mix of roughly 50% U.S. and 50% international markets.
- The company reported a net loss of $1.3 billion on a GAAP basis, driven by a $950 million litigation settlement with Arbutus and Genevant Sciences, though adjusted net loss excluding the settlement was $500 million, down over 50% year-over-year.
- +7 more takeaways
Shenandoah Telecommunications (Shentel) Q1 2026 Earnings Call - Glo Fiber Expansion Hits 449K Passings, EBITDA Jumps 15% as Construction Phase Winds Down
Shenandoah Telecommunications delivered a quarter defined by execution rather than hype. Glo Fiber added 6,000 net customers and 22,000 passings, pushing total expansion passings to 449,000. The compa...
- Glo Fiber added 6,000 net customers in Q1 2026, a 9% improvement year-over-year, bringing total Glo Fiber customers to 94,000.
- Construction momentum remains strong with 22,000 passings added, pushing total Glo Fiber expansion passings to 449,000 out of a 510,000 target for year-end 2026.
- Consolidated adjusted EBITDA grew 15% to $31.7 million, supported by 34.6% revenue growth in Glo Fiber expansion markets.
- +7 more takeaways
Proto Labs Q1 2026 Earnings Call - Record Revenue Driven by Aerospace Demand and Margin Expansion
Proto Labs delivered a record first quarter with revenue of $139.3 million, up 10.4% year-over-year, driven by exceptional demand for CNC machining in aerospace, defense, and robotics. The company ach...
- Revenue hit a record $139.3 million, up 10.4% year-over-year, with U.S. growth of 11.8% offsetting a 3.4% decline in Europe.
- Non-GAAP EPS reached $0.54, the highest level since Q3 2020, driven by volume growth, pricing power, and operating leverage.
- Gross margin expanded 140 basis points to 46.2%, supported by favorable mix and higher factory revenue growth compared to network services.
- +11 more takeaways
Eastman Chemical Q1 2026 Earnings Call - Renew Platform Growth and Middle East Disruption Drive Upside
Eastman Chemical delivered a resilient first quarter in 2026, with management highlighting strong momentum in its Renew platform and Chemical Intermediates (CI) segment. Revenue growth in the Renew po...
- Renew Platform Revenue Growth: Eastman expects 4%-5% revenue growth in its Renew platform, driven by strong demand for recycled PET (rPET) and new wins in specialty plastics like Tritan. Brands are accelerating adoption to secure supply, with Pepsi and others starting purchases ahead of contract obligations.
- Middle East Supply Disruption: The conflict in the Middle East has tightened global chemical supply, particularly in Asia, where competitors face higher oil and natural gas costs. Eastman, with its low-cost, vertically integrated U.S. footprint, is positioned to capture market share and sell all available volume in Chemical Intermediates.
- Chemical Intermediates (CI) Resilience: CI margins are underpinned by tight market conditions and aggressive price increases. Management expects CI EBIT to approach $50 million in Q2 and remain stable in Q3, supported by higher exports to Europe and reduced competition from Asia.
- +7 more takeaways